Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003620240 | SCV004532544 | pathogenic | DNA ligase IV deficiency | 2023-05-22 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with LIG4-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the LIG4 protein in which other variant(s) (p.Arg814*) have been determined to be pathogenic (PMID: 27063650). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant is present in population databases (rs757994549, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Glu776Lysfs*20) in the LIG4 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 136 amino acid(s) of the LIG4 protein. |